Open access · CC-BY
via OpenAlex
Alzheimer’s Disease: Epidemiology and Clinical Progression
Amir Abbas Tahami Monfared, Michael J. Byrnes, Leigh Ann White, Quanwu Zhang
Neurology and Therapy · 2022 · ▲ 628 citations
Abstract
Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of dementia in older individuals (aged ≥ 65 years). To gain a deeper understanding of the recent literature on the epidemiology of AD and its progression, we conducted a review of the PubMed-indexed literature (2014-2021) in North America, Europe, and Asia. The worldwide toll of AD is evidenced by rising prevalence, incidence, and mortality due to AD-estimates which are low because of underdiagnosis of AD. Mild cognitive impairment (MCI) due to AD can ultimately progress to AD dementia; estimates of AD dementia etiology among patients with MCI range from 40% to 75% depending on the populations studied and whether the MCI diagnosis was made clinically or in combination with biomarkers. The risk of AD dementia increases with progression from normal cognition with no amyloid-beta (Aβ) accumulation to early neurodegeneration and subsequently to MCI. For patients with Aβ accumulation and neurodegeneration, lifetime risk of AD dementia has been estimated to be 41.9% among women and 33.6% among men. Data on progression from preclinical AD to MCI are sparse, but an analysis of progression across the three preclinical National Institute on Aging and Alzheimer's Association (NIA-AA) stages suggests that NIA-AA stage 3 (subtle cognitive decline with AD biomarker positivity) could be useful in combination with other tools for treatment decision-making. Factors shown to increase risk include lower Mini-Mental State Examination (MMSE) score, higher Alzheimer's Disease Assessment Scale (ADAS-cog) score, positive APOE4 status, white matter hyperintensities volume, entorhinal cortex atrophy, cerebrospinal fluid (CSF) total tau, CSF neurogranin levels, dependency in instrumental activities of daily living (IADL), and being female. Results suggest that use of biomarkers alongside neurocognitive tests will become an important part of clinical practice as new disease-modifying therapies are introduced.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s40120-022-00338-8
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Monfared, A.A.T., Byrnes, M.J., White, L.A., & Zhang, Q. (2022). Alzheimer’s Disease: Epidemiology and Clinical Progression. <em>Neurology and Therapy</em>. https://doi.org/10.1007/s40120-022-00338-8
Vancouver
Monfared AAT, Byrnes MJ, White LA, Zhang Q. Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurology and Therapy. 2022. doi:10.1007/s40120-022-00338-8.
BibTeX
@article{amir2022Alzhei,
title = {Alzheimer’s Disease: Epidemiology and Clinical Progression},
author = {Amir Abbas Tahami Monfared and Michael J. Byrnes and Leigh Ann White and Quanwu Zhang},
journal = {Neurology and Therapy},
year = {2022},
doi = {10.1007/s40120-022-00338-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer s & Dementia 2011
Open access · OA
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Current Alzheimer Research 2019
Citation only
Biomarkers for Alzheimer’s Disease
Alzheimer s & Dementia 2024
Open access · CC-BY
Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
Journal of Alzheimer's disease : JAD 2026
Open access · OA
Exploring the interplay between frailty, Alzheimer's disease biomarkers, and cognitive functioning in patients with mild cognitive impairment: A cross-sectional study.
Alzheimer s & Dementia 2018
Open access · CC-BY
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Dementia & Neuropsychologia 2016
Open access · CC-BY